文献速递小儿神经外科与脑积水神经重症

脑积水脑室腹腔或脑室心房分流术后迟发性导管相关颅内出血

Delayed Catheter-Related Intracranial Hemorrhage After a Ventriculoperitoneal or Ventriculoatrial Shunt in Hydrocephalus.
PubMed 文献 · World Neurosurg · 2017-08-25

回顾性分析2011年9月至2015年12月218例脑积水行脑室腹腔或脑室心房分流术患者,17例(7.8%)发生迟发性导管相关颅内出血,术后依诺肝素抗凝者出血风险显著增高(25% vs. 6.4%,P=0.026),相对危险度4.8(95%CI:1.4-17.1)。

要点

  • 218例分流术后迟发性导管相关颅内出血发生率为7.8%(17/218)。
  • 脑室腹腔分流组出血7.3%(11/151),脑室心房分流组9.0%(6/67)。
  • 术后依诺肝素抗凝者出血25%(4/16),未抗凝者6.4%(13/202),相对危险度4.8(95%CI:1.4-17.1)。

核心结论

  • 脑室腹腔或脑室心房分流术后迟发性导管相关颅内出血并不少见,但多数患者经适当治疗后可治愈。
  • 术后依诺肝素抗凝治疗可能与出血风险增加相关。

研究设计与样本

  • 回顾性研究,纳入2011年9月至2015年12月本科室收治的218例脑积水行脑室腹腔或脑室心房分流术患者(男145例,女73例)。
  • 采用SPSS 16.0分析迟发性导管相关颅内出血的危险因素。

主要发现

  • 17例(7.8%)发生迟发性导管相关颅内出血,其中脑室腹腔分流组11/151例(7.3%),脑室心房分流组6/67例(9.0%)。
  • 术后接受低分子肝素(LMWH)治疗者出血4/16例(25%),未接受者出血13/202例(6.4%),差异有统计学意义(P=0.026)。
  • 相对危险度为4.8(95%置信区间:1.4-17.1)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Delayed catheter-related intracranial hemorrhage is not rare after a ventriculoperitoneal (VP) or ventriculoatrial (VA) shunt for the treatment of hydrocephalus. Immediate postoperative catheter-related intracranial hemorrhage is possibly due to the procedure itself; however, delayed intracranial hemorrhage may have other underlying mechanisms. This study aimed to investigate the clinical characteristics and reveal the risk factors of delayed catheter-related intracranial hemorrhage after a VP or VA shunt. METHODS: We did a retrospective study to review patients with hydrocephalus and underwent VP or VA shunt in our department from September 2011 to December 2015. We reviewed the clinical characteristics of the patients with delayed catheter-related intracranial hemorrhage, and its risk factors were analyzed with SPSS 16.0. RESULTS: Of the 218 patients enrolled in the study (145 male, 73 female), 17 (7.8%) patients experienced delayed catheter-related intracranial hemorrhage, including 11 of 151 (7.3%) patients with a VP shunt and 6 of 67 (9.0%) patients with a VA shunt. Additionally, 4 of the 16 patients with postoperative low-molecular-weight heparin (LMWH) therapy and 13 of the 202 patients without LMWH experienced bleeding, showing a significant difference (25% vs. 6.4%, P = 0.026). The relative risk was 4.8 (95% confidence interval: 1.4-17.1). CONCLUSION: Delayed catheter-related intracranial hemorrhage is not rare after a VP or VA shunt. However, most patients can be cured after appropriate treatment. Postoperative anticoagulation therapy with enoxaparin may be associated with an increased risk of bleeding.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Qian Z, Gao L, Wang K, et al. Delayed Catheter-Related Intracranial Hemorrhage After a Ventriculoperitoneal or Ventriculoatrial Shunt in Hydrocephalus. World Neurosurg. 2017. PMID: 28847553. doi:10.1016/j.wneu.2017.08.098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。